The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles
We demonstrate here that the genetic incorporation of the fusogenic peptide HA2 into a CXCR4-targeted protein nanoparticle dramatically reduces the specificity of the interaction between nanoparticles and cell receptors, a factor to be considered when designing tumor-homing drug vehicles displaying...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:225214 |
| Acceso en línea: | https://ddd.uab.cat/record/225214 https://dx.doi.org/urn:doi:10.1039/c6cc09900a |
| Access Level: | acceso abierto |
| Palabra clave: | Drug Carriers Endosomes Fluorescence HeLa Cells Hemagglutinins, Viral Humans Nanoparticles Receptors, Cell Surface Receptors, CXCR4 Tumor Cells, Cultured |
| Sumario: | We demonstrate here that the genetic incorporation of the fusogenic peptide HA2 into a CXCR4-targeted protein nanoparticle dramatically reduces the specificity of the interaction between nanoparticles and cell receptors, a factor to be considered when designing tumor-homing drug vehicles displaying endosomal-escape agents. The loss of specificity is concomitant with enhanced cell penetrability. |
|---|